Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DELTa G delirium treatment study
NL-OMON29295Recruiting
- Sponsor
- Novartis
- Start
- Jan 2006
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial in delirium comparing Haloperidol, Rivastigmine and Placebo (3 arms). Primary endpoint: Length of delirium. Started Jan 2006; status: recruiting.
02
Drugs
rivastigminehaloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on NL-OMON29295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29295.